Screener / SEC EDGAR /CIK 0001159036 /10-K filed Feb 17, 2026, compared with Feb 18, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Halozyme Therapeutics, Inc. HALO

Compare with peers Embed
Filings with the SEC since Jan 9, 2012

996 filings, 2 in the last 30 days

SEC filing index

What the 8-Ks said

5 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.

CEO, CFO, COO or CAO: 5 (item 5.02)Auditor change: 0 (item 4.01)Not to be relied on: 0 (item 4.02)Cybersecurity: 0 (item 1.05)Restructuring: 0 (item 2.05)Listing notice: 0 (item 3.01)Impairment: 0 (item 2.06)Debt trigger: 0 (item 2.04)
  • Jul 2, 2026 CEO, CFO, COO or CAOCOO change “The company also announced the departure of Cortney Caudill as the Company’s Senior Vice President, Chief Operating Officer.” 8-K item 5.02 · all documents
  • Apr 30, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) announced that Darren Snellgrove has been appointed to serve as the Company’s Chief Financial Officer (“CFO”), effective June 8, 2026.” 8-K item 5.02 · all documents
  • Mar 12, 2026 CEO, CFO, COO or CAOCFO change “(the “Company”) announced that David Ramsay has been appointed to serve as the Company’s Interim Chief Financial Officer (“Interim CFO”), effective March 23, 2026.” 8-K item 5.02 · all documents
  • Nov 24, 2025 CEO, CFO, COO or CAOCFO change “(“the Company”) announced a transition plan in which Nicole LaBrosse, Senior Vice President, Chief Financial Officer will continue to serve as the Company’s Chief Financial Officer until the earliest of when a new chief financial officer is hired, March 30, 2026 or such earlier date determined by the Company (the “Separation Date”) and then depart to pursue a new professional opportunity.” 8-K item 5.02 · all documents
  • Nov 3, 2025 CEO, CFO, COO or CAOCFO change “The Company announced today a transition plan in which Nicole LaBrosse, Senior Vice President and Chief Financial Officer (“CFO”) will continue to serve as the Company’s CFO until the earlier of when a new chief financial officer is hired, or until March 30, 2026 (the “Separation Date”) and then depart to pursue a new professional opportunity.” 8-K item 5.02 · all documents

From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.

Late filings, 8-K notices and going concern

None found in the last 2 years

All checks
  • Late filing notices (NT 10-K, NT 10-Q)
    No notice in the last 2 years.
  • 8-K notices: listing, impairment, debt trigger
    No item 3.01, 2.06 or 2.04 in the last 2 years.
  • Going-concern language in the 10-K
    No statement of substantial doubt in the latest 10-K.

Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.

Every filing on one line

Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)Planned insider sale (Form 144, 10b5-1)
All 61 events

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind · each form links to sec.gov

FiledFormWhat it is
Nov 5, 2026 10-Q Quarterly report
Nov 5, 2026 8-K Quarterly results
Oct 8, 2026 4 Insider trade
Oct 8, 2026 4/A Insider trade (amended)
Oct 2, 2026 4 Insider trade
Oct 2, 2026 3 New insider
Oct 2, 2026 4 Insider trade
Sep 30, 2026 8-K Director or officer change
Sep 22, 2026 8-K Material agreement signed, New debt or obligation, Unregistered share sale
Sep 18, 2026 8-K Other events
Sep 17, 2026 4 Insider trade
Sep 16, 2026 144 Notice of planned insider sale
Sep 16, 2026 8-K Other events
Sep 11, 2026 4 Insider trade
Sep 2, 2026 4 Insider trade
Aug 21, 2026 3 New insider
Aug 19, 2026 4 Insider trade
Aug 18, 2026 8-K Director or officer change
Aug 17, 2026 144 Notice of planned insider sale
Aug 11, 2026 144 Notice of planned insider sale
Aug 11, 2026 4 Insider trade
Aug 10, 2026 144 Notice of planned insider sale
Aug 6, 2026 10-Q Quarterly report
Aug 6, 2026 8-K Quarterly results
Jul 9, 2026 4 Insider trade
Jul 2, 2026 4 Insider trade
Jul 2, 2026 4 Insider trade
Jul 2, 2026 4 Insider trade
Jul 2, 2026 8-K Director or officer change
Jun 30, 2026 4 Insider trade
Jun 29, 2026 144 Notice of planned insider sale
Jun 15, 2026 4 Insider trade
Jun 9, 2026 3 New insider
Jun 3, 2026 4 Insider trade
Jun 2, 2026 4 Insider trade
May 15, 2026 144 Notice of planned insider sale
May 13, 2026 4 Insider trade
May 11, 2026 144 Notice of planned insider sale
May 11, 2026 10-Q Quarterly report
May 11, 2026 8-K Quarterly results
May 7, 2026 4 Insider trade
May 7, 2026 4 Insider trade
May 7, 2026 4 Insider trade
May 7, 2026 4 Insider trade
May 7, 2026 4 Insider trade
May 7, 2026 4 Insider trade
May 7, 2026 8-K Shareholder vote results
May 5, 2026 4 Insider trade
May 1, 2026 144 Notice of planned insider sale
Apr 30, 2026 SCHEDULE 13G 5%+ owner (passive)
Apr 30, 2026 8-K Director or officer change
Apr 24, 2026 8-K Bylaws or fiscal year changed
Apr 7, 2026 4 Insider trade
Apr 2, 2026 4 Insider trade
Apr 2, 2026 4 Insider trade
Mar 27, 2026 SCHEDULE 13G/A 5%+ owner (passive), amended
Mar 23, 2026 3 New insider
Mar 23, 2026 ARS Annual report to shareholders
Mar 23, 2026 DEFA14A Extra proxy material
Mar 23, 2026 DEF 14A Proxy statement
Mar 12, 2026 8-K Director or officer change
Mar 10, 2026 144 Notice of planned insider sale
Mar 10, 2026 4 Insider trade
Mar 9, 2026 144 Notice of planned insider sale
Mar 4, 2026 4 Insider trade
Feb 24, 2026 4 Insider trade
Feb 24, 2026 4 Insider trade
Feb 24, 2026 4 Insider trade
Feb 24, 2026 4 Insider trade
Feb 17, 2026 4 Insider trade
Feb 17, 2026 4 Insider trade
Feb 17, 2026 4 Insider trade
Feb 17, 2026 10-K Annual report
Feb 17, 2026 8-K Quarterly results
Feb 11, 2026 4 Insider trade
Feb 11, 2026 4 Insider trade
Feb 11, 2026 4 Insider trade
Feb 11, 2026 4 Insider trade
Feb 5, 2026 4 Insider trade
Feb 3, 2026 144 Notice of planned insider sale
Jan 28, 2026 8-K Quarterly results
Jan 6, 2026 4 Insider trade
Jan 6, 2026 4 Insider trade
Jan 6, 2026 4 Insider trade
Jan 5, 2026 144 Notice of planned insider sale
Jan 5, 2026 3 New insider
Dec 19, 2025 4 Insider trade
Dec 11, 2025 4 Insider trade
Dec 9, 2025 8-K Director or officer change
Dec 8, 2025 8-K Director or officer change
Dec 1, 2025 4 Insider trade
Dec 1, 2025 4 Insider trade
Nov 24, 2025 8-K Director or officer change
Nov 18, 2025 S-8 Shares registered for employee plans
Nov 12, 2025 8-K Material agreement signed, New debt or obligation, Unregistered share sale
Nov 12, 2025 4 Insider trade
Nov 12, 2025 4 Insider trade
Nov 7, 2025 8-K Other events
Nov 5, 2025 8-K Material agreement signed, New debt or obligation, Other events
Nov 3, 2025 10-Q Quarterly report
Show the other 75 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Sources

SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.

Also

Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HALO/export.csv") into a cell.

Next:Earnings releases
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.